The current literature suggests that pericellular proteolysis via the uPA system (uPAS) plays a crucial role in enabling tumour cell invasion, migration and metastasis in pancreatic cancer, including PDAC, and that overexpression of uPAS components is correlated with poorer clinicopathological features and shortened patient survival. This evidence concerns the gene PLAU and familial pancreatic carcinoma.